Overview of Low Back Pain Disorders
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Facet Joint Pathology
CLINICAL Facet Joint Pathology REVIEW Indexing Metadata/Description › Title/condition: Facet Joint Pathology › Synonyms: Facet joint syndrome; zygapophyseal joint pathology; facet joint arthropathy › Anatomical location/body part affected: Spine, specifically facet joint/s › Area(s) of specialty: Orthopedic rehabilitation › Description • Facet joints(1) –Fall under the category of synovial joints –Also called zygapophyseal joints • Types of facet joint pathology(1) –Sprain –Trauma to the capsule –Degenerative joint disease/osteoarthritis –Rheumatoid arthritis –Impingement - Pain and spasm result upon injury to the meniscoid - Generally occurs when the individual completes a quick or atypical movement - The movement typically entails spinal flexion and rotation –Prevalence of facet joint pathology has been estimated to be between 15% and 45% in patients with chronic low back pain(29) › ICD-9 codes • 724.8 other symptoms referable to back [facet syndrome] › ICD-10 codes • M24.8 other specific joint derangements, not elsewhere classified • M53.8 other specified dorsopathies • M54.5 low back pain Authors • M54.8 other dorsalgia Amy Lombara, PT, DPT • optional subclassification to indicate site of involvement for M53 and M54 Ellenore Palmer, BScPT, MSc –0 multiple sites in spine Cinahl Information Systems, Glendale, CA –5 thoracolumbar region Reviewers –6 lumbar region Rudy Dressendorfer, BScPT, PhD –7 lumbosacral region Cinahl Information Systems, Glendale, CA –8 sacral and sacrococcygeal region Lynn Watkins, BS, PT, OCS –9 site unspecified -
Clinical Data Mining Reveals Analgesic Effects of Lapatinib in Cancer Patients
www.nature.com/scientificreports OPEN Clinical data mining reveals analgesic efects of lapatinib in cancer patients Shuo Zhou1,2, Fang Zheng1,2* & Chang‑Guo Zhan1,2* Microsomal prostaglandin E2 synthase 1 (mPGES‑1) is recognized as a promising target for a next generation of anti‑infammatory drugs that are not expected to have the side efects of currently available anti‑infammatory drugs. Lapatinib, an FDA‑approved drug for cancer treatment, has recently been identifed as an mPGES‑1 inhibitor. But the efcacy of lapatinib as an analgesic remains to be evaluated. In the present clinical data mining (CDM) study, we have collected and analyzed all lapatinib‑related clinical data retrieved from clinicaltrials.gov. Our CDM utilized a meta‑analysis protocol, but the clinical data analyzed were not limited to the primary and secondary outcomes of clinical trials, unlike conventional meta‑analyses. All the pain‑related data were used to determine the numbers and odd ratios (ORs) of various forms of pain in cancer patients with lapatinib treatment. The ORs, 95% confdence intervals, and P values for the diferences in pain were calculated and the heterogeneous data across the trials were evaluated. For all forms of pain analyzed, the patients received lapatinib treatment have a reduced occurrence (OR 0.79; CI 0.70–0.89; P = 0.0002 for the overall efect). According to our CDM results, available clinical data for 12,765 patients enrolled in 20 randomized clinical trials indicate that lapatinib therapy is associated with a signifcant reduction in various forms of pain, including musculoskeletal pain, bone pain, headache, arthralgia, and pain in extremity, in cancer patients. -
Approach to Polyarthritis for the Primary Care Physician
24 Osteopathic Family Physician (2018) 24 - 31 Osteopathic Family Physician | Volume 10, No. 5 | September / October, 2018 REVIEW ARTICLE Approach to Polyarthritis for the Primary Care Physician Arielle Freilich, DO, PGY2 & Helaine Larsen, DO Good Samaritan Hospital Medical Center, West Islip, New York KEYWORDS: Complaints of joint pain are commonly seen in clinical practice. Primary care physicians are frequently the frst practitioners to work up these complaints. Polyarthritis can be seen in a multitude of diseases. It Polyarthritis can be a challenging diagnostic process. In this article, we review the approach to diagnosing polyarthritis Synovitis joint pain in the primary care setting. Starting with history and physical, we outline the defning characteristics of various causes of arthralgia. We discuss the use of certain laboratory studies including Joint Pain sedimentation rate, antinuclear antibody, and rheumatoid factor. Aspiration of synovial fuid is often required for diagnosis, and we discuss the interpretation of possible results. Primary care physicians can Rheumatic Disease initiate the evaluation of polyarthralgia, and this article outlines a diagnostic approach. Rheumatology INTRODUCTION PATIENT HISTORY Polyarticular joint pain is a common complaint seen Although laboratory studies can shed much light on a possible diagnosis, a in primary care practices. The diferential diagnosis detailed history and physical examination remain crucial in the evaluation is extensive, thus making the diagnostic process of polyarticular symptoms. The vast diferential for polyarticular pain can difcult. A comprehensive history and physical exam be greatly narrowed using a thorough history. can help point towards the more likely etiology of the complaint. The physician must frst ensure that there are no symptoms pointing towards a more serious Emergencies diagnosis, which may require urgent management or During the initial evaluation, the physician must frst exclude any life- referral. -
Pathological Cause of Low Back Pain in a Patient Seen Through Direct Margaret M
Pathological Cause of Low Back Pain in a Patient Seen through Direct Margaret M. Gebhardt PT, DPT, OCS Access in a Physical Therapy Clinic: A Case Report Staff Physical Therapist, Motion Stability, LLC, and Adjunct Clinical Faculty, Mercer University, Atlanta, GA ABSTRACT cal therapists primarily treat patients that sporadic.9 Deyo and Diehl6 found that the Background and Purpose: A 66-year- fall into the mechanical LBP category, but 4 clinical findings with the highest positive old male presented directly to a physical need to be aware that although infrequent, likelihood ratios for detecting the presence therapy clinic with complaints of low back 7% to 8% of LBP complaints are due to of cancer in LBP were: a previous history of pain (LBP). The purpose of this case report is nonmechanical spinal conditions or visceral cancer, failure to improve with conservative to describe the clinical reasoning that led to disease.5 Malignant neoplasms are the most medical treatment in the past month, an age a medical referral for a patient not respond- common of the nonmechanical spinal con- of at least 50 years or older, and unexplained ing to conservative treatment that ultimately ditions causing LBP, but comprise less than weight loss of more than 4.5 kg in 6 months led to the diagnosis of multiple myeloma. 1% of all total LBP conditions.6 (Table 1).10 In Deyo and Diehl’s6 study, they Methods: Data was collected during the In this era of autonomous practice, analyzed 1975 patients that presented with course of the patient’s treatment in an out- increasing numbers of physical therapists are LBP and found 13 to have cancer. -
The IASP Classification of Chronic Pain for ICD-11: Chronic Cancer-Related
Narrative Review The IASP classification of chronic pain for ICD-11: chronic cancer-related pain Michael I. Bennetta, Stein Kaasab,c,d, Antonia Barkee, Beatrice Korwisie, Winfried Riefe, Rolf-Detlef Treedef,*, The IASP Taskforce for the Classification of Chronic Pain Abstract 10/27/2019 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3FlQBFFqx6X+GYXBy6C6D13N3BXo5wGkearAMol2nLQo= by https://journals.lww.com/pain from Downloaded Downloaded Worldwide, the prevalence of cancer is rising and so too is the number of patients who survive their cancer for many years thanks to the therapeutic successes of modern oncology. One of the most frequent and disabling symptoms of cancer is pain. In addition to from the pain caused by the cancer, cancer treatment may also lead to chronic pain. Despite its importance, chronic cancer-related pain https://journals.lww.com/pain is not represented in the current International Classification of Diseases (ICD-10). This article describes the new classification of chronic cancer-related pain for ICD-11. Chronic cancer-related pain is defined as chronic pain caused by the primary cancer itself or metastases (chronic cancer pain) or its treatment (chronic postcancer treatment pain). It should be distinguished from pain caused by comorbid disease. Pain management regimens for terminally ill cancer patients have been elaborated by the World Health Organization and other international bodies. An important clinical challenge is the longer term pain management in cancer patients by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3FlQBFFqx6X+GYXBy6C6D13N3BXo5wGkearAMol2nLQo= and cancer survivors, where chronic pain from cancer, its treatment, and unrelated causes may be concurrent. This article describes how a new classification of chronic cancer-related pain in ICD-11 is intended to help develop more individualized management plans for these patients and to stimulate research into these pain syndromes. -
An Unusual Cause of Back Pain in Osteoporosis: Lessons from a Spinal Lesion
Ann Rheum Dis 1999;58:327–331 327 MASTERCLASS Series editor: John Axford Ann Rheum Dis: first published as 10.1136/ard.58.6.327 on 1 June 1999. Downloaded from An unusual cause of back pain in osteoporosis: lessons from a spinal lesion S Venkatachalam, Elaine Dennison, Madeleine Sampson, Peter Hockey, MIDCawley, Cyrus Cooper Case report A 77 year old woman was admitted with a three month history of worsening back pain, malaise, and anorexia. On direct questioning, she reported that she had suVered from back pain for four years. The thoracolumbar radiograph four years earlier showed T6/7 vertebral collapse, mild scoliosis, and degenerative change of the lumbar spine (fig 1); but other investigations at that time including the eryth- rocyte sedimentation rate (ESR) and protein electophoresis were normal. Bone mineral density then was 0.914 g/cm2 (T score = −2.4) at the lumbar spine, 0.776 g/cm2 (T score = −1.8) at the right femoral neck and 0.738 g/cm2 (T score = −1.7) at the left femoral neck. She was given cyclical etidronate after this vertebral collapse as she had suVered a previous fragility fracture of the left wrist. On admission, she was afebrile, but general examination was remarkable for pallor, dental http://ard.bmj.com/ caries, and cellulitis of the left leg. A pansysto- lic murmur was heard at the cardiac apex on auscultation; there were no other signs of bac- terial endocarditis. She had kyphoscoliosis and there was diVuse tenderness of the thoraco- lumbar spine. Her neurological examination was unremarkable. on September 29, 2021 by guest. -
Sacroiliac Joint Dysfunction a Case Study
NOR200188.qxd 3/8/11 9:53 PM Page 126 Sacroiliac Joint Dysfunction A Case Study CPT William Murray Pain is a widespread issue in the United States. Nine of physical therapist. She was evaluated and her treatment 10 Americans regularly suffer from pain, and nearly every consisted of a transcutaneous electrical nerve stimula- person will experience low back pain at one point in their lives. tion unit while in the PT clinic, aqua therapy, and ice Undertreated or unrelieved pain costs more than and heat application. $60 billion a year from decreased productivity, lost income, After several weeks, Ms. T returned to the primary care and medical expenses. The ability to diagnose and provide ap- provider and informed her that the pain has not decreased and “feels like that it is getting worse.” She also informed propriate medical treatment is imperative. This case study ex- the provider that she was having difficulty sleeping and amines a 23-year-old Active Duty woman who is preparing to constantly feeling tired secondary to pain. Throughout the be involuntarily released from military duty for an easily cor- next several months, the primary care provider tried nu- rectable medical condition. She has complained of chronic low merous medication trials with no relief for the patient. Ms. back pain that radiates into her hip and down her leg since ex- T gives a history of being prescribed numerous medica- periencing a work-related injury. She has been seen by numer- tions within several drug classifications. She stated vari- ous providers for the previous 11 months before being referred ous side effects that are related to the medications and to the chronic pain clinic. -
Indications for and Benefits of Lumbar Facet Joint Block: Analysis of 230 Consecutive Patients
Neurosurg Focus 13 (2):Article 11, 2002, Click here to return to Table of Contents Indications for and benefits of lumbar facet joint block: analysis of 230 consecutive patients ALAN BANI, M.D., UWE SPETZGER, M.D., AND JOACHIM M. GILSBACH, M.D. Department of Neurosurgery, Klinikum Duisburg-Wedau, Duisburg; Department of Neurosurgery, Municipal Hospital Klinikum, Karlsruhe; and Department of Neurosurgery, Medical Faculty, University of Technology, Aachen, Germany Object. The authors evaluated the effectiveness of using a facet joint block with local anesthetic agents and or steroid medication for the treatment of low-back pain in a medium-sized series of patients. Methods. Over a period of 4 years, the authors performed 715 facet joint injections in 230 patients with variable- length histories of low-back pain. The main parameter for the success or failure of this treatment was the relief of the pain. For the first injection—mainly a diagnostic procedure—the authors used a local anesthetic (1 ml bupivacaine 1%). In cases of good response, betamethasone was injected in a second session to achieve a longer-lasting effect. Long-lasting relief of the low-back pain and/or leg pain was reported by 43 patients (18.7%) during a mean follow- up period of 10 months. Thirty-five patients (15.2%) noticed a general improvement in their pain. Twenty-seven patients (11.7%) reported relief of low-back pain but not leg pain. Nine patients (3.9%) suffered no back pain but still leg pain. One hundred sixteen patients (50.4%), however, experienced no improvement of pain at all. -
Pain Management & Palliative Care
Guidelines on Pain Management & Palliative Care A. Paez Borda (chair), F. Charnay-Sonnek, V. Fonteyne, E.G. Papaioannou © European Association of Urology 2013 TABLE OF CONTENTS PAGE 1. INTRODUCTION 6 1.1 The Guideline 6 1.2 Methodology 6 1.3 Publication history 6 1.4 Acknowledgements 6 1.5 Level of evidence and grade of guideline recommendations* 6 1.6 References 7 2. BACKGROUND 7 2.1 Definition of pain 7 2.2 Pain evaluation and measurement 7 2.2.1 Pain evaluation 7 2.2.2 Assessing pain intensity and quality of life (QoL) 8 2.3 References 9 3. CANCER PAIN MANAGEMENT (GENERAL) 10 3.1 Classification of cancer pain 10 3.2 General principles of cancer pain management 10 3.3 Non-pharmacological therapies 11 3.3.1 Surgery 11 3.3.2 Radionuclides 11 3.3.2.1 Clinical background 11 3.3.2.2 Radiopharmaceuticals 11 3.3.3 Radiotherapy for metastatic bone pain 13 3.3.3.1 Clinical background 13 3.3.3.2 Radiotherapy scheme 13 3.3.3.3 Spinal cord compression 13 3.3.3.4 Pathological fractures 14 3.3.3.5 Side effects 14 3.3.4 Psychological and adjunctive therapy 14 3.3.4.1 Psychological therapies 14 3.3.4.2 Adjunctive therapy 14 3.4 Pharmacotherapy 15 3.4.1 Chemotherapy 15 3.4.2 Bisphosphonates 15 3.4.2.1 Mechanisms of action 15 3.4.2.2 Effects and side effects 15 3.4.3 Denosumab 16 3.4.4 Systemic analgesic pharmacotherapy - the analgesic ladder 16 3.4.4.1 Non-opioid analgesics 17 3.4.4.2 Opioid analgesics 17 3.4.5 Treatment of neuropathic pain 21 3.4.5.1 Antidepressants 21 3.4.5.2 Anticonvulsant medication 21 3.4.5.3 Local analgesics 22 3.4.5.4 NMDA receptor antagonists 22 3.4.5.5 Other drug treatments 23 3.4.5.6 Invasive analgesic techniques 23 3.4.6 Breakthrough cancer pain 24 3.5 Quality of life (QoL) 25 3.6 Conclusions 26 3.7 References 26 4. -
Sacroiliac Joint Dysfunction and Piriformis Syndrome
Classic vs. Functional Movement Approach in Physical Therapy Setting Crista Jacobe-Mann, PT Nevada Physical Therapy UNR Sports Medicine Center Reno, NV 775-784-1999 [email protected] Lumbar Spine Intervertebral joints Facet joints Sacroiliac joint Anterior ligaments Posterior ligaments Pelvis Pubic symphysis Obturator foramen Greater sciatic foramen Sacrospinous ligament Lesser sciatic foramen Sacrotuberous ligament Hip Capsule Labrum Lumbar spine: flexion and extension ~30 total degrees of rotation L1-L5 Facet joints aligned in vertical/saggital plane SI joints 2-5 mm in all directions, passive movement, not caused by muscle activation Shock absorption/accepting load with initial contact during walking Hip Joints Extension 0-15 degrees 15% SI joint pain noted in chronic LBP patients Innervation: L2-S3 Classic signs and symptoms Lower back pain generally not above L5 transverse process Pain can radiate down posterior thigh to posterior knee joint, glutes, sacrum, iliac crest sciatic distribution Pain with static standing, bending forward, donning shoes/socks, crossing leg, rising from chair, rolling in bed Relief with continuous change in position Trochanteric Bursitis Piriformis Syndrome Myofascial Pain Lumbosacral Disc Herniation and Bulge Lumbosacral Facet Syndrome J. Travell suspects Si joint pain may causes piriformis guarding and lead to Piriformis syndrome… Tenderness to palpation of PSIS, lower erector spinae, quadratus lumborum and gluteal muscles Sometimes positive SLR Limited hip mobility -
Facet Syndrome
A MEDICAL-LEGAL NEWSLETTER FOR PERSONAL INJURY ATTORNEYS BY DR. STEVEN W.SHAW Facet Syndrome The concept of facet joint mediated pain is not a new concept but it is one that is overlooked frequently in the medical legal world and commonly misinterpreted as radiculopathy by many lay “experts”. Facet joint pain, also commonly known as facet syndrome, is pain that originates from the posterior joints of the vertebral motor unit. The joints of the vertebral motor unit include two adjacent vertebra and the related intervertebral disc in the anterior and the two facet joints in the posterior. These posterior joints are also known as the Apophyseal joints, Zygopophyseal joints, Zed joints, Z joints. For purposes of this newsletter, I will be discussing primarily Lumbar Facet syndrome but most of the concepts will apply also to the cervical spine. Characteristic symptoms of facet mediated pain include localized unilateral spine pain, Localized facet or transverse process pain to palpation, pain directly over the joint capsule, lack of radicular features (dermatomal distribution or motor weakness), pain reduced on flexion, Pain worse with extension and loading, referred pain not extending beyond the knee or elbow, pain reduction after diagnostic facet or medial branch blockade. It is important to point out that facet joint pain, both in the neck and lower back, may have a referral pattern to the extremities but it does not follow a regional dermatomal pattern. A dermatomal pattern of referral is expected with a disc herniation with resulting nerve root involvement or other nerve root compromising lesions and will follow the anatomical distribution of the sensory root for that nerve. -
PATIENT FACT SHEET Chronic Recurrent Multifocal Osteomyelitis (CRMO)
PATIENT FACT SHEET Chronic Recurrent Multifocal Osteomyelitis (CRMO) Chronic recurrent multifocal osteomyelitis (CRMO), or thought to be rare, occurring in about 0.4 out of 100,000 chronic nonbacterial osteomyelitis (CNO), is an auto- people per year. As recognition of CRMO is increasing, it inflammatory disorder that causes bone pain due to appears to be more common than that. In fact, CRMO may inflammation in the bones not caused by infection. be nearly as common as bone infections. The average age CONDITION Chronic recurrent multifocal osteomyelitis (CRMO) can that CRMO starts is 9 to 10 years. More girls are affected take months to years to diagnose. CRMO was previously than boys. DESCRIPTION Bone pain is the most common symptom. There is a genetic component. Some families have more than one usually tenderness at the affected site (it hurts to be person with CRMO. pushed on). The pain can cause the person to avoid using CRMO is monitored by following symptoms and imaging the affected body part. Some people with CRMO can studies. MRI is the best way to assess resolution of active develop arthritis (joint swelling). Fatigue is common during bone lesions and/or detect new lesions. active disease. A small fraction of people with CRMO have SIGNS/ SYMPTOMS Treatment of CRMO depends on how severe it is and zoledronic acid). People taking methotrexate and biologic which bones it affects. Treatment usually starts with medications are at a higher risk of infection and should be NSAID medications (ibuprofen, naproxen, meloxicam), evaluated by a doctor if they develop fever or symptoms but some patients need stronger medicines, including of infection.